期刊文献+

利福平壳聚糖复合体的制备及表征 被引量:1

Preparation and Characterization of Rifampicin-chitosan Complex
下载PDF
导出
摘要 壳聚糖是自然界存在的唯一的碱性多糖,无毒,具有体内生物降解性,其来源于虾蟹类壳,大量使用还能解决沿海虾蟹类壳的去向问题,因此是一种理想可开发的海洋资源。应用壳聚糖制备的缓释剂不仅缓释作用明显,且在体内不会蓄积。利福平对结核杆菌和其他分支杆菌(包括麻风杆菌等),在宿主细胞内、外均有明显的杀菌作用。通过超声波法制备了利福平壳聚糖复合体并用现代分析方法进行了表征,并探讨了在人工胃液中的释药性能。 Chitosan is a kind of alkalescence amylase that existed in the nature exclusively,no poisonous and biodegradable.The large quantity usage can still resolve problem of shell of shrimp and crab along the sea,therefore this is a kind of ideal ocean resource we can research.Sustained release preparation is a new product with many advantages including accurate curative effect,few bad responses,and good patient s compliance.Its are not only provided with good function of sustained-release,but also couldn t accumu...
出处 《武汉理工大学学报》 EI CAS CSCD 北大核心 2008年第3期46-49,共4页 Journal of Wuhan University of Technology
关键词 壳聚糖 缓释剂 利福平 制备 表征 chitosan sustained release preparations rifampicin preparation characterization
  • 相关文献

参考文献6

  • 1[1]Aspden T J.Chitosan as a Nasal Delivery System:Evaluation of Insulin Absorption Enhancement and Effect on Nasal Membrane Intergrity Using Rat Models Eur[J].J Pharm Sci,1996,4(1):23.
  • 2高怀生,黄是是,张世达,谷长泉,高兰兴.壳聚糖-诺氟沙星烧伤生物敷料的研究[J].军事医学科学院院刊,1993,17(1):16-19. 被引量:8
  • 3[3]Dangprasirt P.Development of Diclofenac Sodium Controlled Release Solid Dispersion Powders and Capsules by Freeze Drying Technique Using Ethylcellulose and Chitosan as Carries[J].Drug Dev Ind Pharm,1998,24(10):947.
  • 4[4]Kanke M,katayama H,Tsuzuki S,et al.Application of Chitin and Chitisan to Pharmaceutical Preparation.I.Film Preparation and invitro evaluation[J].Chem Pharm Bull,1989,37:523.
  • 5[5]Yongmei Xu,Yumin Du.Effect of Molecular Structure of Chitosan on Protein Delivery Properties of Chitosan Nanoparticles[J].International Journal of Pharmaceutics,2003,(250):215.
  • 6孙毅毅,侯世祥,陈彤,何军,袁子雁.壳聚糖-聚乙二醇接枝共聚物的合成与表征[J].四川大学学报(工程科学版),2005,37(2):76-79. 被引量:9

二级参考文献6

  • 1Peracchia M T, Fattal E, Desmaele D. Stealth PEGyhdted polycyanoacrylate nanoparticles for intravenous adminstration and splenic targeting[J]. J Controlled Release, 1999,60:121 - 130.
  • 2Gref R, Lack M, Quellec P, et al. ‘ Stealth' corona-core nanopatticles stufar modifled by polyethylene glycol(PEG) :influences of the corona (PEG chain length and surface density)and of the cote composition on phagocytic uptake and plasma protein adsorption[J]. Colloids Surf B Biointerfacea,2000,18(3 -4):301-308.
  • 3Charels O, Beaurhamp S, Steven L, et al. A new procedure for the synthesis of polyethylene glycol-protein adducs; effecs on function,receptor recognition, and dearawm of superoxide dismutase,lactoferrin,and α2 - macroglobulin[J]. Analytical Biochemistry, 1983,131(1) :25 - 33.
  • 4李伟军,郑春辉,张达磊,张颖,苏志国.聚乙二醇修饰牛血清白蛋白的反应与分析[J].生物技术通讯,2001,12(3):164-166. 被引量:5
  • 5高蓉,姜忠义.两相体系分光光度法测定聚乙二醇化蛋白质混合物中游离聚乙二醇[J].分析试验室,2003,22(4):44-46. 被引量:4
  • 6汪杨,吴伟.隐形纳米粒的体内靶向性[J].中国药学杂志,2004,39(1):7-11. 被引量:27

共引文献15

同被引文献18

  • 1覃沐.中毒生物检材中斑蝥素的SPE/GC/MS分析[J].广西警官高等专科学校学报,2006,19(S1). 被引量:1
  • 2费俭,顾球.疏水层析法纯化青霉素酰化酶[J].生物化学与生物物理学报,1989,21(4):315-321. 被引量:2
  • 3曹炳军,王俊忠.去甲斑蝥素合成工艺的改进[J].天津药学,1995,7(2):35-36. 被引量:9
  • 4刘力,徐德生,谢德隆,徐晓敏.斑蝥体中斑螯素的紫外分光光度测定法[J].中国中药杂志,1989,14(7):40-41. 被引量:11
  • 5施志坚,刘卫霞,曹卫国,梁超.一类环丙烷衍生物的简易合成及波谱学结构表征[J].波谱学杂志,2007,24(2):155-161. 被引量:1
  • 6Nan Kai University(南开大学),Sun Yat sen University(中山大学),Peking University(北京大学),et al.Entomology(昆虫学)[M].Beijing(北京):People's Education Press(人民教育出版社),1982.148.
  • 7LiuYi(刘毅) LingYangzhi(凌仰之).Synthensis of exo- norcantharidint(外型去甲斑蝥素的合成).中国医药工业杂志,1991,22(1):8-13.
  • 8I.iu Xiao-hua(刘晓华), Wan Sia Heng, Paul, et al. Novel polymeric microspheres containing norcantharidin for chemoembolization[J]. J Control Release, 2006, 116(1):35-41.
  • 9WangGuang-sheng(王广生) LiRongchang(李荣昌) DouPei-yah(窦培延).Existent states of norcantharidin in gastrointestinal fluid(去甲斑蝥素在胃肠液中的存在状态).药学学报,1984,19(8):24-26.
  • 10Jennette A S, Stephen P A, Monique L B, etal. Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues[J]. Invest New Drug, 2002, 20(1):1-11.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部